RE:RE:RE:Accelerated Approval Good to see that the FDA is challenging Big Pharma on these drugs. Even if BP has ways to put pressure on the FDA, we see that in the end data is King. May TLD-1433 be the supreme King in bladder cancer with unparalleled data, and GBM and NSCLC to follow.
Jaro1977 wrote:
https://www.fiercepharma.com/marketing/fda-convenes-adcom-to-review-accelerated-approvals-failed-trials-threatening-merck